Business Context and Reporting Period
Zurn Elkay Water Solutions Corp (ZWS) filed its Form 10-Q for the quarter ended June 30, 2024. The company is a growth-oriented, pure-play water management business providing specification-driven solutions for health, hydration, and safety. The reporting period covers the three and six months ended June 30, 2024, compared to the same periods in 2023. The company operates under the Zurn Elkay Business System (ZEBS) philosophy and completed the Elkay Merger in July 2022.
Key Financial Metrics
| Metric (in Millions) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Sales | $412.0 | $403.2 | $785.8 | $775.3 |
| Gross Profit | $186.3 | $173.5 | $356.4 | $322.3 |
| Income from Operations | $71.9 | $54.8 | $125.1 | $98.5 |
| Net Income | $46.0 | $34.6 | $80.3 | $57.4 |
| Diluted EPS | $0.27 | $0.20 | $0.46 | $0.32 |
| Operating Cash Flow (YTD) | $139.0 | $92.2 | $139.0 | $92.2 |
| Cash and Equivalents (End of Period) | $162.7 | $103.0 | $162.7 | $103.0 |
| Total Debt | $495.5 | $495.3 | $495.5 | $495.3 |
Margins (Q2 2024 vs Q2 2023): Gross margin improved to 45.2% from 43.0%. Operating margin expanded to 17.5% from 13.6%.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2.2% in Q2 and 1.4% YTD. Core sales growth of 2% was offset by a planned exit of certain residential sink products.
- Profitability Expansion: Operating income rose 31.2% in Q2 and 27.0% YTD. This was driven by productivity synergies from the Elkay Merger, lower material and transportation costs, and reduced restructuring expenses compared to the prior year.
- Restructuring Charges: Charges decreased significantly to $0.7 million in Q2 2024 from $7.8 million in Q2 2023. YTD charges were $7.0 million versus $9.7 million in the prior year.
- Interest Expense: Net interest expense declined to $8.5 million in Q2 from $10.3 million, primarily due to interest earned on higher cash balances.
- Share Repurchases: The company repurchased 1.94 million shares in Q2 2024 at a weighted average price of $31.38, totaling $61.0 million. YTD repurchases totaled $79.9 million.
Guidance, Outlook, and Risks
Management Commentary: Management expects to continue executing restructuring initiatives to optimize operating margins and manufacturing footprint. The company anticipates further expenses related to workforce reductions and facility rationalization, though the full extent is not yet estimable. The company maintains a disciplined approach to capital allocation, evidenced by continued share buybacks and dividend payments.
Dividends: On July 25, 2024, the Board declared a quarterly cash dividend of $0.08 per share, payable September 6, 2024.
Backlog: As of June 30, 2024, backlog was $59.6 million. The company expects to recognize approximately 99% of this backlog in the remaining six months of 2024.
Risks and Contingencies:
- Asbestos Liabilities: The company divested asbestos liabilities in December 2023. While obligations were removed from the balance sheet, the company retains indemnification obligations for breaches of representations unrelated to asbestos.
- Tax Matters: The company is subject to periodic income tax examinations in domestic and foreign jurisdictions. It maintains valuation allowances against certain deferred tax assets.
- Debt Covenants: The company is compliant with its credit agreement covenants. The Net First Lien Leverage Ratio was 0.98 to 1.00 as of June 30, 2024, well below the maximum of 5.00 to 1.00.
Investor Verification Checklist
- Verify the sustainability of the 390 basis point operating margin expansion in Q2 2024, specifically the impact of lower material costs and restructuring run-rates.
- Confirm the timeline and financial impact of the planned exit of residential sink products on future revenue guidance.
- Review the remaining $310.6 million in share repurchase authority and the company's commitment to capital return versus reinvestment.
- Monitor the execution of ongoing restructuring initiatives and the potential for future non-cash charges related to asset impairments.
- Assess the impact of foreign currency translation on future earnings, given the company's exposure to international markets (Canada and Rest of World).